On September 12, 2024, Rady A Johnson, the Executive Vice President of Pfizer Inc [PFE], was reported to have engaged in a transaction involving the company's stock. The details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. As a result, the number of shares held by Johnson after the action remains unknown. This information is critical for investors who track insider transactions as indicators of the company's performance and management's confidence in the business.

On September 12, 2024, Rady A Johnson, the Executive Vice President of Pfizer Inc [PFE], was reported to have engaged in a transaction involving the company's stock. The details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. As a result, the number of shares held by Johnson after the action remains unknown. This information is critical for investors who track insider transactions as indicators of the company's performance and management's confidence in the business.